Core Viewpoint - United Homes Group, Inc. (UHG) is under investigation for potential violations of federal securities laws, which may impact investor confidence and the company's market performance [1]. Investigation Details - The investigation is initiated by the Law Offices of Frank R. Cruz on behalf of investors who may have suffered financial losses due to UHG's actions [1]. - UHG disclosed on October 20, 2025, that six of its board members are involved in the investigation, raising concerns about corporate governance and compliance [1].

Core Viewpoint - A securities class action lawsuit has been filed against Fortinet, Inc. for allegedly making false and misleading statements regarding its business operations and product refresh cycle during the specified Class Period from November 8, 2024, to August 6, 2025 [1][2]. Allegations of Misconduct - The lawsuit claims that Fortinet misrepresented the profitability of its product refresh cycle, stating it would be lucrative despite it consisting of older products that represented only a small portion of the business [2]. - It is alleged that Fortinet did not accurately disclose the actual number of FortiGate firewalls eligible for upgrades, leading to misleading statements about the company's operational capabilities [2]. - The complaint asserts that Fortinet misled investors by claiming that the refresh would gain momentum over two years, while in reality, the company had pushed through about half of the refresh in just a few months by the end of Q2 2025 [2]. - As a result of these actions, the statements made by Fortinet regarding its business, operations, and future prospects were materially false and lacked a reasonable basis [2]. Lead Plaintiff Process - Investors in Fortinet have until November 21, 2025, to seek appointment as a lead plaintiff representative in the class action, which involves directing the litigation on behalf of all class members [3]. - The lead plaintiff is typically the investor or group of investors with the largest financial interest in the case and is responsible for selecting legal counsel to represent the class [3]. Firm Background - Kessler Topaz Meltzer & Check, LLP is known for prosecuting class actions and has a reputation for recovering significant amounts for victims of corporate misconduct [4].

Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims of overstated demand for its Prestige fragrances [1][2][3]. Group 1: Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrance, color cosmetics, and skin and body care products. Prestige fragrances represent 60% of the company's revenues [2]. Group 2: Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as weaknesses in U.S. execution, retailer inventory buildup, and challenges from previous fiscal year innovations [3]. - The company's stock price fell by $1.05 per share, a decline of over 21%, from $4.86 on August 20, 2025, to $3.81 on August 21, 2025, following the announcement of these results [3]. Group 3: Market Dynamics - Coty indicated that retailers were maintaining tight inventory levels, while in reality, they were overstocked due to a decline in demand for Coty's products [2]. - The company experienced a slowdown in cosmetics sales attributed to value-seeking consumer behavior, fatigue with innovation, and specific U.S. factors such as in-store security measures and immigration policy changes [3].

Core Viewpoint - A class action lawsuit has been filed against Baxter International Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of Illinois, captioned Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International Inc., et al., No. 1:25-cv-12672 [3]. - Investors have until December 15, 2025, to request to be appointed to lead the case [3]. Group 2: Product Issues - Baxter's Novum IQ Large Volume pump, a key growth driver, faced serious malfunctions after its launch in Canada, including under-infusion and over-infusion of medications [4][5]. - The company previously claimed that the Novum LVP had advanced safety features and that the Canadian rollout would help resolve any issues, which was later alleged to be misleading [5]. Group 3: Stock Impact - Following the announcement on July 31, 2025, to pause shipments and installations of the Novum LVP, Baxter's stock price fell by $6.29 per share, a decline of over 22%, from $28.05 to $21.76 [6].

Core Insights - Simulations Plus, Inc. is under investigation for potential violations of federal securities laws following disappointing financial results and issues with internal controls [1][3]. Company Overview - Simulations Plus is a software company specializing in modeling and simulation tools for the pharmaceutical, biotechnology, and chemical industries [2]. Acquisition Details - In June 2024, Simulations Plus acquired Pro-ficiency Holdings, Inc., aiming to double its total addressable market and enhance sales [2][3]. Financial Performance and Stock Impact - On April 15, 2025, Simulations Plus hired Grant Thornton LLP as its new auditor, which was followed by a significant stock price drop after the company announced disappointing preliminary financial results for Q3 2025 on June 11, 2025, with a decline of over 24% from $26.44 to $20.05 per share [4]. - The company reported a $77.2 million charge related to prior acquisitions in its Q3 2025 financial results on July 14, 2025, and subsequently dismissed Grant Thornton, citing unresolved matters regarding segment reporting and internal controls [5]. Auditor Dispute - Grant Thornton disagreed with Simulations Plus's characterizations regarding internal controls and reporting, leading to further stock price decline of nearly 26% from $17.47 to $12.97 per share following the announcement of the impairment charge and auditor findings [5].

SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23, 2025, inclusive (the “Class Period”), have until Tuesday, October 28, 2025 to seek appointment as lead plaintiff of the Dow class action lawsuit. Captioned Sarti v. Dow Inc., No. 25-cv-12744 (E.D. Mich.), the Dow class action lawsuit charges Dow, The Dow Chemical Company, a Dow subsidiary, and certain of ...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming October 21, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Nutex Health Inc. ("Nutex†or the "Company†) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the "Class Period†). IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE TO PARTICIPATE IN THE SECURIT. ...

Core Viewpoint - A securities class action lawsuit has been filed against Lantheus Holdings, Inc. for allegedly making false and misleading statements regarding its product PYLARIFY and its competitive position during the class period from February 26, 2025, to August 5, 2025 [1][2]. Group 1: Allegations Against Lantheus - The lawsuit claims that Lantheus misled investors about the competitive position of PYLARIFY, failing to properly assess pricing and competitive dynamics [2]. - It is alleged that Lantheus did not disclose that a price increase in early 2025, despite previous price erosion, created opportunities for competitive pricing, which could jeopardize PYLARIFY's revenue and growth potential [2]. - The complaint asserts that the public statements made by Lantheus were materially false and misleading throughout the relevant period [2]. Group 2: Legal Process and Investor Information - Investors in Lantheus have until November 10, 2025, to seek appointment as lead plaintiff in the class action, which involves directing the litigation on behalf of all class members [3]. - A lead plaintiff is typically the investor or group of investors with the largest financial interest in the case, and they will select counsel to represent the class [3]. - Investors who have suffered significant losses are encouraged to contact Kessler Topaz Meltzer & Check, LLP for more information regarding the lawsuit [4].

Core Viewpoint - Fly-E Group, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between July 15, 2025, and August 14, 2025 [1][2]. Summary by Relevant Sections Class Action Details - The lawsuit claims that Fly-E provided misleading positive statements while concealing material adverse facts about the safety of its lithium batteries, which adversely affected E-vehicle sales revenue [2]. - On August 14, 2025, Fly-E disclosed a 32% decrease in net revenues, primarily due to a drop in total units sold, attributed to recent lithium-battery accidents involving E-Bikes and E-Scooters [2]. - Following this disclosure, Fly-E's stock price plummeted from $7.76 per share to $1.00 per share, marking an approximate 87% decline in just one day [2]. Next Steps for Investors - Investors who suffered losses during the specified timeframe have until November 10, 2025, to request appointment as lead plaintiff, although participation does not require serving in this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Accessibility StatementSkip Navigation NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our te ...